KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)
About KEWAUNEE SCIENTIFIC CORP /DE/
Kewaunee Scientific Corp is engaged in the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. Its products include steel and wood casework, fume hoods, adaptable modular systems, movable workstations, stand-alone benches, biological safety cabinets, epoxy resin work surfaces, and sinks. The company operates through two reportable segments: Lab Products Group (LPG), which designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, flexible systems, work surfaces, workstations, workbenches, and computer enclosures, and the International segment.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $240.5M
- Net income
- $11.4M
- Total assets
- $194.7M
- Market cap
- $103.3M
- Gross margin
- 28.5%
- Operating margin
- 5.9%
- Net margin
- 3.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $282.0M
- Cost of revenue
- $201.6M
- Gross profit
- $80.4M
- Operating expenses
- $63.7M
- Operating income
- $16.7M
- Income tax
- $3.3M
- Net income
- $10.5M
- EPS (basic)
- $3.36
- EPS (diluted)
- $3.22
Balance sheet
- Total assets
- $178.3M
- Current assets
- $105.4M
- Total liabilities
- $101.5M
- Current liabilities
- $48.4M
- Shareholders’ equity
- $76.8M
Cash flow
- Operating cash flow
- $18.6M
- Investing cash flow
- -$3.9M
- Financing cash flow
- -$19.3M
- Net cash flow
- -$5.5M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $103.3M
- P/E ratio
- 11.2
- EPS (diluted)
- $3.22
- Dividend yield
- 2.11%
- Shares outstanding
- 3.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 1, 1972
Kewaunee Scientific Corp /DE/ (KEQU) Stock Price
- Profitable — net income of $11.4M in FY2025.
- Revenue grew 67% from FY2022 to FY2026.
- Gross margin of 28.5%, net margin 3.7%.
- Trading 40% below its 52-week high.
- Pays a dividend yielding about 2.11% annually.
- Valued at a price-to-earnings (P/E) ratio of 11.2.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review KEWAUNEE SCIENTIFIC CORP /DE/.
Write a review
News about KEWAUNEE SCIENTIFIC CORP /DE/
News & sentiment via Polygon.io
Kewaunee Scientific Corp /DE/: frequently asked questions
Is Kewaunee Scientific Corp /DE/ an American company?
Kewaunee Scientific Corp /DE/ is a US-based company headquartered in Statesville, North Carolina, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Kewaunee Scientific Corp /DE/ headquartered?
Kewaunee Scientific Corp /DE/ is headquartered in Statesville, North Carolina, United States.
Is Kewaunee Scientific Corp /DE/ publicly traded?
Yes — Kewaunee Scientific Corp /DE/ is a publicly traded company. Its stock trades under the ticker symbol KEQU on the NASDAQ.
What does Kewaunee Scientific Corp /DE/ do?
Kewaunee Scientific Corp /DE/ is an American Medical Devices company in the Health & Beauty sector.
